Describe imaging characteristics and evaluate the role of 18FDG-PET/CT in the diagnosis of cervical lymph nodes in nasopharyngeal cancer patients.

Toàn Nguyễn Quang1,, Tran Thanh Binh2
1 Bv K
2 K Hospital

Main Article Content

Abstract

Purpose: Describe imaging characteristics and evaluate the role of 18FDG-PET/CT in the diagnosis of cervical lymph nodes in nasopharyngeal cancer patients.


Subjects and methods: Prospective description of 60 patients with nasopharyngeal carcinoma identified by biopsy and histopathology and untreated (in which 55 patients with undifferentiated carcinoma and 5 patients with squamous cell carcinoma), were taken with 18FDG PET/CT and compared with ultrasound and done FNA lymph nodes respectively, from June 2018 to July 2019 to K Central Hospital, Tan Trieu campus. All 18FDG-PET/CT films were read preoperatively and compared with their respective locations on ultrasound and lymph node FNA.


Results: In total 60 patients common age is 52.3±11.1, male/female ≈ 5/1; A total of 379 bilateral cervical lymph nodes on PET/CT, 195 lymph nodes in the left neck are common (51.5%), the most common lymph node location in group II (96.7% of patients and 61% of total lymph nodes), There are 322/379 (85%) lymph nodes with structural loss on ultrasound, there is a correlation between lymph node size and lymph node absorption on 18FDG-PET/CT with r=0.6, cervical lymph node groups 322/379 Structural abnormal lymph nodes with SUVmax = 9.5 ± 4.6 (nearly 4 times higher than 57/379 normal lymph nodes with SUVmax = 2.6 ± 2.5). In a total of 379 lymph nodes over 60 patients, there was a close agreement between the lymph nodes with loss of umbilical fat structure on ultrasound with SUVmax>2.5 threshold of 92.9% (kappa=0.67) and better at the threshold. SUVmax>3.5 was 92.9% (Cohen's kappa=0.75) on PET/CT. In addition, cytology was positive in 60/89 lymph nodes undergoing FNA, which was in close concordance with ultrasonography of loss of hilar fat structure and cytological diagnosis of 83.4% (Cohen's kappa = 0.62). ). The cytological diagnosis was mild with increased uptake with SUVmax>2.5 threshold of 75.3% (Cohen's kappa = 0.3), but there was a strong correlation when the lymph node imaging was increased. Absorption with SUVmax >2.5 on PET/CT and loss of umbilical cord fat on ultrasound with cytological diagnosis was 87.6% (Cohen's kappa = 0.69). In particular, out of a total of 340/379 lymph nodes with threshold SUVmax>2.5 on PET/CT are considered as metastatic nodes, changing the stage of 25/60 patients (41.67%); in which 17 patients increased and 8 patients decreased stage N compared with staging by other imaging methods before having PET/CT.


Conclusion: 18FDG-PET/CT scan is an imaging method with accurate diagnostic value in diagnosing cervical lymph nodes in patients with cervical cancer, useful for treatment planning.

Article Details

References

1. Chen Y.K, Su C.T, Ding H.J et al. (2006), “Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients”, Anticancer Res, 26, pp.1471-1477.
2. Ak, S., Kiliç, C., & Özlügedik, S. (2021). Correlation of PET-CT, MRI and histopathology findings in the follow-up of patients with nasopharyngeal cancer. Brazilian Journal of Otorhinolaryngology, 87, 643-648.
3. Mohandas A, Marcus C, Kang H, Truong MT, Subramaniam RM. FDG PET/CT in the management of nasopharyngeal carcinoma. AJR Am J Roentgenol. 2014 Aug;203(2):W146-57. doi: 10.2214/AJR.13.12420. PMID: 25055290
4. Nghiêm Đức Thuận (2002), Nghiên cứu đặc điểm lâm sàng, mô bệnh học và hoạt tính gen vi rút Epstein - Barr trong ung thư vòm họng, Luận án tiến sỹ, Học viện Quân y.
5. Trần Hải Bình (2018), Nghiên cứu vai trò của 18FDG-PET/CT trong chẩn đoán giai đoạn và mô phỏng lập kế hoạch xạ trị ung thư vòm mũi họng, Luận án Tiến sĩ Y học, Học viện Quân y, Hà Nội-2018.
6. NCCN Guidelines, version 1.2015: Head and Neck cancers. J. Nat Compr Canc. Netw. 13(7): 847-856
7. Lin X.P, Zhao C, Chen M.Y, et al. (2008), “Role of 18FDG-PET/CT in diagnosis and staging of nasopharyngeal carcinoma”, Chines J. of cancer, 27(9): 259-262.
8. Ridge A, Mehra R, Lango N, et al. (2016), Cancer management, Head and Neck Tumors, published on Cancer Network.
9. AJCC Cancer Staging Manual (2018), Eighth Edition.
10. King A.D, Ma B.B, Yau Y.Y, et al. (2008), “The impact of 18FDG-PET/CT on assessment of nasopharyngeal carcinoma in diagnosis”, Br J Radiol, 81(964): 291-298.
11. Ng S.H, Chan S.C, Yen T.C, et al. (2009), “Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work up”, Eur J Nucl Med Mol Imaging, 36(1): 12-22
12. Hannah A, Scott A.M, Tochon-Danguy H, et al. (2002), “Evaluation of 18FDG positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer”, Ann Surg, 236: 208-217.